[{"Assets_0_Q1_USD":1680968000.0,"CommonStockSharesConverted_0_Q1_shares":105345000.0,"CommonStockSharesOutstanding_0_Q1_shares":86054000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":34378000.0,"NetIncomeLossConverted_1_Q1_USD":102709000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":87549000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":86204000.0,"StockholdersEquity_0_Q1_USD":51562000.0,"StockholdersEquityConverted_0_Q1_USD":51870000.0,"EarningsPerShareBasic_1_Q1_USD":1.19,"EarningsPerShareDiluted_1_Q1_USD":1.17,"RevenuesConverted_1_Q1_USD":576056000.0,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20190501"}]